What Reviews May Miss About Prolonged Grief Disorder - Takeaways - MDSpire

What Reviews May Miss About Prolonged Grief Disorder

When targeted evidence gets diluted, effective treatments for prolonged grief disorder may be harder to see—and use.

  • By

  • Kerri Miller

  • April 6, 2026

  • 3 min

Share

  • 1

    The AHRQ review may underrepresent the evidence base for prolonged grief disorder (PGD), impacting clinical care.

  • 2

    Interpersonal psychotherapy for PGD shows a 71% response rate, significantly higher than the 44% for citalopram.

  • 3

    The AHRQ review's grouping of heterogeneous psychotherapy studies may dilute the effectiveness signals for PGD-specific interventions.

  • 4

    PGD is recognized in DSM-5-TR and has validated diagnostic tools and effective therapies demonstrated in randomized trials.

  • 5

    Digital grief interventions show promise, but scalability and implementation challenges remain for PGD treatment.

Original Source(s)

What Reviews May Miss About Prolonged Grief Disorder

  • by Kerri Miller

  • April 6, 2026

Related Content

Institutional trauma, absence of accountability, and psychopathology in a juvenile serial homicide case

Side Effects: They Googled It

Patients are mining Reddit and TikTok for symptom intel while you're not — and a small study calls it epistemic injustice. Different knowledge, mutually unrecognized. Maybe ask where they've been reading before you wave it off as anecdote.

Evaluating the impact of integrated care clinics on Asian American populations’ mental health